Revelation Biosciences REVB
NASDAQ REVB
$0.77 -0.03 (-3.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Revelation Biosciences (REVB) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Revelation Biosciences' Return on Capital Employed [ROCE] was -94.77% in Q2 2026, up 165.61 percentage points from -260.39% a year earlier but down 10.14 percentage points from the prior quarter.

Analysis

Revelation Biosciences (REVB) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Revelation Biosciences came in at -127.68%, down 21.40 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a five-year change of -122.84 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -106.28% in FY2024 (+156.59 pp), -262.87% in FY2023 and -33.23% in FY2021 (-28.39 pp).
  • Quarterly Return on Capital Employed [ROCE] has moved between -21927.04% (Q2 2022) and -33.51% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for five straight quarters, with an average year-over-year change of +40.26 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2023 (a gain of 21879.10 percentage points); the worst was Q4 2022 (a drop of 644.89 percentage points).
  • Per Business Quant data, REVB's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -84.63% (Q1 2026), -88.74% (Q4 2025) and -113.50% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Revelation Biosciences 3.01 Mn -46.01 Mn - -94.77%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -94.77%
Mar 31, 2026 -84.63%
Dec 31, 2025 -88.74%
Sep 30, 2025 -113.50%
Jun 30, 2025 -260.39%
Mar 31, 2025 -194.17%
Dec 31, 2024 -167.28%
Sep 30, 2024 -157.16%
Jun 30, 2024 -404.35%
Mar 31, 2024 -108.63%
Dec 31, 2023 -113.15%
Sep 30, 2023 -77.60%
Jun 30, 2023 -47.94%
Mar 31, 2023 -158.99%
Dec 31, 2022 -678.40%
Sep 30, 2022 -1,345.04%
Jun 30, 2022 -21,927.04%
Dec 31, 2021 -33.51%
API Access

Revelation Biosciences Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=REVB&period=max&api_key=YOUR_API_KEY